Genetic and epigenetic studies offer new therapeutic options for the treatment of T-cell acute lymphoblastic leukemia

被引：1
|
作者：
Cools, Jan [1 ,2 ]
机构：
[1] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium
[2] VIB, Ctr Biol Dis, Louvain, Belgium
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2012年 / 97卷 / 03期
关键词：
OF-FUNCTION MUTATIONS; IL7R;
D O I：
10.3324/haematol.2012.064501
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：323 / 323
页数：1
相关论文
共 50 条
  • [1] The epigenetic landscape of T-cell acute lymphoblastic leukemia
    Van der Meulen, Joni
    Van Roy, Nadine
    Van Vlierberghe, Pieter
    Speleman, Frank
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 53 : 547 - 557
  • [2] Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options
    Zhao, YiFan
    Guo, RuiTing
    Cao, XinPing
    Zhang, Yi
    Sun, Rui
    Lu, WenYi
    Zhao, MingFeng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [3] The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
    Lato, Marta Weronika
    Przysucha, Anna
    Grosman, Sylwia
    Zawitkowska, Joanna
    Lejman, Monika
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [4] The Epigenetic and Genetic Landscapes of Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Kimura, Shunsuke
    Seki, Masafumi
    Kawai, Tomoko
    Yoshida, Kenichi
    Isobe, Tomoya
    Ueno, Hiroo
    Shiozawa, Yusuke
    Suzuki, Hiromichi
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Ohki, Kentaro
    Kato, Motohiro
    Koh, Katsuyoshi
    Hanada, Ryoji
    Kobayashi, Ryoji
    Deguchi, Takao
    Hashii, Yoshiko
    Imamura, Toshihiko
    Sato, Atsushi
    Kiyokawa, Nobutaka
    Manabe, Atushi
    Horibe, Keizo
    Ohara, Akira
    Sanada, Masashi
    Kobayashi, Masao
    Oka, Akira
    Hayashi, Yasuhide
    Miyano, Satoru
    Hata, Kenichiro
    Ogawa, Seishi
    Takita, Junko
    [J]. BLOOD, 2017, 130
  • [5] Integrated Genetic and Epigenetic Analysis in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Kimura, S.
    Seki, M.
    Kawai, T.
    Yoshida, K.
    Isobe, T.
    Ueno, H.
    Suzuki, H.
    Oki, K.
    Imamura, T.
    Kiyokawa, N.
    Kobayashi, M.
    Koh, K.
    Manabe, A.
    Ohara, A.
    Sanada, M.
    Hayashi, Y.
    Hata, K.
    Miyano, S.
    Ogawa, S.
    Takita, J.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S31 - S31
  • [6] PDGFR-β As a New Therapeutic Target in T-Cell Acute Lymphoblastic Leukemia
    De Coninck, Stien
    De Smedt, Renate
    Lintermans, Beatrice
    Goossens, Steven
    Van Vlierberghe, Pieter
    [J]. BLOOD, 2022, 140 : 11513 - 11514
  • [7] Emerging Treatment Options for Acute Lymphoblastic Leukemia: Focus on CAR T-Cell Therapy
    Brown, Patrick A.
    Shah, Bijal
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05): : 651 - 655
  • [8] New Approaches to T-Cell Acute Lymphoblastic Leukemia
    Teachey, David T.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 295 - 298
  • [9] Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia
    De Keersmaecker, Kim
    Marynen, Peter
    Cools, Jan
    [J]. HAEMATOLOGICA, 2005, 90 (08) : 1116 - 1127
  • [10] Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
    Cani, Alice
    Simioni, Carolina
    Martelli, Alberto M.
    Zauli, Giorgio
    Tabellini, Giovanna
    Ultimo, Simona
    McCubrey, James A.
    Capitani, Silvano
    Neri, Luca M.
    [J]. ONCOTARGET, 2015, 6 (09) : 6597 - 6610
12345